Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 201–300 of 1,004
Humphries, S. E., Gable, D., Cooper, J. A., Ireland, H., Stephens, J. W., Hurel, S. J., Li, K. W., Palmen, J., Miller, M. A., Cappuccio, F. P., et al. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0108-7 · Cited by 167
“It has previously been reported that the effect of this genotype is essentially codominant [7], and our data confirm this finding.”
BackgroundResultInfluentialThyroid hormone-related regulation of gene expression in human fatty liver.
Pihlajamäki, J., Boes, T., Kim, E.-Y., Dearie, F., Kim, B. W., Schroeder, J., Mun, E., Nasser, I., Park, P. J., Bianco, A. C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0212 · Cited by 164
“Interestingly, expression of TCF7L2, a high-ranking T2DM candidate gene (25), was down-regulated by 35% (P 0.”
BackgroundWnt-Lrp5 Signaling Regulates Fatty Acid Metabolism in the Osteoblast
Frey, J. L., Li, Z., Ellis, J. M., Zhang, Q., Farber, C. R., Aja, S., Wolfgang, M. J., Clemens, T. L., & Riddle, R. C. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01343-14 · Cited by 162
“pathway components are associated with an increased risk for the development of diabetes (30, 31), obesity (32), and hyperlipidemia (33, 34).”
BackgroundGenetics of type 2 diabetes: the GWAS era and future perspectives [Review]
Imamura, M., & Maeda, S. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0113 · Cited by 164
Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine β-Cell Function
Staiger, H., Machicao, F., Stefan, N., Tschritter, O., Thamer, C., Kantartzis, K., Schäfer, S. A., Kirchhoff, K., Fritsche, A., & Häring, H.-U. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000832 · Cited by 162
“In fact, among the most prominent T2DM risk loci up to now, only SNPs within PPARG [3–5] contribute to altered insulin sensitivity, whereas SNPs within KCNJ11 [6–8], CDKAL1 [9], and TCF7L2 [10–13] impair b-cell function.”
BackgroundRare and Common Genetic Events in Type 2 Diabetes: What Should Biologists Know?
Bonnefond, A., & Froguel, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.020 · Cited by 163
“Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.”
BackgroundInfluentialRobitaille, J., & Grant, A. M. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b8710 · Cited by 163
TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Villareal, D. T., Robertson, H., Bell, G. I., Patterson, B. W., Tran, H., Wice, B., & Polonsky, K. S. (2010) · Diabetes · doi:10.2337/db09-1169 · Cited by 162
“Recently, polymorphisms in the transcription factor 7-like 2 gene (TCF7L2) have been associated with type 2 diabetes (1), increasing risk 1.”
BackgroundPlunkett, J., & Muglia, L. J. (2008) · Annals of Medicine · doi:10.1080/07853890701806181 · Cited by 162
Cholesterol in islet dysfunction and type 2 diabetes
Brunham, L. R., Kruit, J. K., Verchere, C. B., & Hayden, M. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33296 · Cited by 158
“Interestingly, even for the transcription factor-7–like 2 (TCF7L2) gene, one of the genes with the strongest genetic evidence for involvement in the pathogenesis of T2D (71, 72), the effect on”
BackgroundType 2 Diabetes Genetics: Beyond GWAS
Sanghera, D. K., & Blackett, P. R. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000198 · Cited by 191
Genetics of diabetes – Are we missing the genes or the disease?
Groop, L., & Pociot, F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.002 · Cited by 191
Chesi, A., Wagley, Y., Johnson, M. E., Manduchi, E., Su, C., Lu, S., Leonard, M. E., Hodge, K. M., Pippin, J. A., Hankenson, K. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09302-x · Cited by 158
Self-citationGenetics of the polycystic ovary syndrome
Kosova, G., & Urbanek, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.009 · Cited by 156
Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study
Vaxillaire, M., Veslot, J., Dina, C., Proença, C., Cauchi, S., Charpentier, G., Tichet, J., Fumeron, F., Marre, M., Meyre, D., et al. (2008) · Diabetes · doi:10.2337/db07-0615 · Cited by 157
“2 (6,7), two intronic polymorphisms in the protease calpain-10 (CAPN10, SNP-43 and -44) (8), and more recently TCF7L2 variants, which have the most important risk effect (9,10).”
BackgroundMolecular mechanisms underlying nutrient-stimulated incretin secretion
Parker, H. E., Reimann, F., & Gribble, F. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900132x · Cited by 155
Sachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 158
WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4
Hammarstedt, A., Hedjazifar, S., Jenndahl, L., Gogg, S., Grünberg, J., Gustafson, B., Klimcakova, E., Stich, V., Langin, D., Laakso, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211255110 · Cited by 158
“To what extent this is associated with the TCF7L2 or other risk genotypes (29) is under investigation.”
BackgroundHayashi, T., Iwamoto, Y., Kaku, K., Hirose, H., & Maeda, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0618-z · Cited by 167
Macdougall, C. E., Wood, E. G., Loschko, J., Scagliotti, V., Cassidy, F. C., Robinson, M. E., Feldhahn, N., Castellano, L., Voisin, M.-B., Marelli-Berg, F., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.007 · Cited by 154
“Variants of the TCF7/2 gene are linked to increased susceptibility for type 2 diabetes (Grant et al., 2006), while a SNP in the human WNT10b gene has been associated with early-onset familial obesity (Christodoulides et al., 2006).”
BackgroundAnimal models for diabetes: Understanding the pathogenesis and finding new treatments
King, A., & Bowe, J. E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.108 · Cited by 176
Boomsma, D. I., Willemsen, G., Sullivan, P. F., Heutink, P., Meijer, P., Sondervan, D., Kluft, C., Smit, G., Nolen, W. A., Zitman, F. G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201979 · Cited by 158
Cellular Plasticity within the Pancreas— Lessons Learned from Development
Puri, S., & Hebrok, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.005 · Cited by 157
Yi, F., Sun, J., Lim, G. E., Fantus, I. G., Brubaker, P. L., & Jin, T. (2008) · Endocrinology · doi:10.1210/en.2007-1142 · Cited by 157
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 152
Corella, D., Carrasco, P., Sorlí, J. V., Estruch, R., Rico-Sanz, J., Martínez-González, M. Á., Salas-Salvadó, J., Covas, M. I., Coltell, O., Arós, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0955 · Cited by 153
Lyon, H. N., Emilsson, V., Hinney, A., Heid, I. M., Lasky-Su, J. A., Zhu, X., Þorleifsson, G., Gunnarsdottir, S., Walters, G. B., Þorsteinsdóttir, U., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030061 · Cited by 167
“The genotyping procedure has been previously described [24].”
MethodSelf-citationTransferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Sim, X., Ong, R. T.-H., Suo, C., Tay, W.-T., Liu, J., Ng, D. P.-K., Boehnke, M., Chia, K.-S., Wong, T.-Y., Seielstad, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001363 · Cited by 152
“These genome-wide association studies (GWAS) have identified a number of novel loci harboring common variants that are associated with an increased risk of T2D [4–11], adding to the loci previously identified by candidate gene studies (PPARG [12], KCNJ11 [13–14], WFS1 [15–16]) and linkage studies TCF7L2 [17–19]).”
BackgroundHorikoshi, M., Hara, K., Ito, C., Nagai, R., Froguel, P., & Kadowaki, T. (2007) · Diabetologia · doi:10.1007/s00125-006-0588-6 · Cited by 161
“Recently, the Icelandic group reported that genetic variations located in introns of TCF7L2 were significantly associated with type 2 diabetes in samples from Icelandic, Danish and US populations [4].”
BackgroundGenetic variant effects on gene expression in human pancreatic islets and their implications for T2D
Viñuela, A., Varshney, A., van de Bunt, M., Prasad, R. B., Asplund, O., Bennett, A., Boehnke, M., Brown, A. A., Erdos, M. R., Fadista, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18581-8 · Cited by 152
Replication of Genome-Wide Association Studies of Type 2 Diabetes Susceptibility in Japan
Horikawa, Y., Miyake, K., Yasuda, K., Enya, M., Hirota, Y., Yamagata, K., Hinokio, Y., Oka, Y., Iwasaki, N., Iwamoto, Y., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0452 · Cited by 151
“A strongly associated type 2 diabetes gene, transcription factor 7-like 2, has been identified by a genome-wide linkage study (1).”
BackgroundMcCubrey, J. A., Rakus, D., Gizak, A., Steelman, L. S., Abrams, S. L., Lertpiriyapong, K., Fitzgerald, T. L., Yang, L. V., Montalto, G., Cervello, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.004 · Cited by 162
The emerging genetics of type 2 diabetes
Bonnefond, A., Froguel, P., & Vaxillaire, M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.06.004 · Cited by 176
Greco, E. A., Lenzi, A., & Migliaccio, S. (2015) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018815611004 · Cited by 145
“In particular, it seems that estrogens simultaneously induce osteogenesis and inhibit adipogenesis both in vivo and in vitro [Guo et al. 2006; Mani et al. 2007; Grant et al. 2006], and it has been demonstrated that estrogens modulate osteoadipogenic transdifferentiation in a dose-dependent manner [Gao et al.”
BackgroundType 2 diabetes: genetic data sharing to advance complex disease research
Flannick, J. A., & Florez, J. C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.56 · Cited by 175
Replication Study of Candidate Genes Associated With Type 2 Diabetes Based On Genome-Wide Screening
Tabara, Y., Osawa, H., Kawamoto, R., Onuma, H., Shimizu, I., Miki, T., Kohara, K., & Makino, H. (2009) · Diabetes · doi:10.2337/db07-1785 · Cited by 146
“For example, transcription factor 7-like 2 (TCF7L2) is a highly reliable predisposing gene for T2DM [1-3].”
BackgroundAssociations between diabetic retinopathy and systemic risk factors
Wat, N., Wong, R. L. M., & Wong, I. Y. (2016) · Hong Kong Medical Journal · doi:10.12809/hkmj164869 · Cited by 171
Genome-wide association studies: progress and potential for drug discovery and development
Kingsmore, S. F., Lindquist, I. E., Mudge, J., Gessler, D. D. G., & Beavis, W. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2519 · Cited by 191
Genetic Analysis of Adult-Onset Autoimmune Diabetes
Howson, J. M. M., Rosinger, S., Smyth, D. J., Boehm, B. O., the ADBW-END Study Group, & Todd, J. A. (2011) · Diabetes · doi:10.2337/db11-0364 · Cited by 143
“For the TCF7L2 and FTO loci, the effect estimates as reported for type 2 diabetes were used (39,40).”
BackgroundGenetic determinants of hepatic steatosis in man
Hooper, A. J., Adams, L. A., & Burnett, J. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r008896 · Cited by 142
Pilgaard, K. A., Jensen, C. B., Schou, J. H., Lyssenko, V., Wegner, L., Brøns, C., Vilsbøll, T., Hansen, T. F., Madsbad, S., Holst, J. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1307-x · Cited by 147
“It has been suggested that the association with type 2 diabetes may be mediated through defects in the enteroinsular axis [3, 12, 13].”
BackgroundKumar, S., Reynolds, K., Ji, Y., Gu, R., Rai, S., & Zhou, C. J. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9268-y · Cited by 153
TCF1 links GIPR signaling to the control of beta cell function and survival
Campbell, J. E., Ussher, J. R., Mulvihill, E. E., Kolic, J., Baggio, L. L., Cao, X., Liu, Y., Lamont, B. J., Morii, T., Streutker, C. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.3997 · Cited by 142
Genetics of Ischemic Stroke, Stroke-Related Risk Factors, Stroke Precursors and Treatments
Della‐Morte, D., Guadagni, F., Palmirotta, R., Testa, G., Caso, V., Paciaroni, M., Abete, P., Rengo, F., Ferroni, P., Sacco, R. L., et al. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.14 · Cited by 147
Ethical, Legal, and Social Implications of Biobanks for Genetics Research
Haga, S. B., & Beskow, L. M. (2008) · Advances in genetics · doi:10.1016/s0065-2660(07)00418-x · Cited by 155
“controversial public debate, the company has published several high profile papers (Amundadottir et al., 2006; Grant et al., 2006; Helgadottir et al. 2006) and continues to work towards the development of diagnostic and therapeutic products based on their research.”
BackgroundKoslowski, M. J., Kübler, I., Chamaillard, M., Schaeffeler, E., Reinisch, W., Wang, G., Beisner, J., Teml, A., Peyrin‐Biroulet, L., Winter, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004496 · Cited by 150
“An association of two noncoding SNPs in the TCF-4 gene has been observed with diabetes mellitus [30] and, in another study, an association with deletions and insertions of adenines in the coding region was reported in patients with colorectal cancer [22].”
BackgroundWNT Signaling: an Emerging Mediator of Cancer Cell Metabolism?
Sherwood, V. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00992-14 · Cited by 142
Genetic dissection of type 2 diabetes
Ridderstråle, M., & Groop, L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.002 · Cited by 156
“TCF7L2: By far the strongest association with T2D is seen for SNPs in the gene encoding the transcription factor-7-like 2 (TCF7L2) (26).”
BackgroundRestricted Adipogenesis in Hypertrophic Obesity
Gustafson, B., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2013) · Diabetes · doi:10.2337/db13-0473 · Cited by 142
“This is also supported by the large prospective Dallas Heart Study in which markers of ectopic fat accumulation, but not subcutaneous fat, predicted risk of developing T2D in obese individuals (4).”
BackgroundInfluentialLinks between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Crunkhorn, S., & Patti, M.-E. (2008) · Thyroid · doi:10.1089/thy.2007.0249 · Cited by 140
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
Saponaro, C., Gaggini, M., & Gastaldelli, A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0607-4 · Cited by 159
The grainyhead like 2 gene (GRHL2), alias TFCP2L3, is associated with age-related hearing impairment
Laer, L. V., Eyken, E. V., Fransén, E., Huyghe, J. R., Topsakal, V., Hendrickx, J. J., Hannula, S., Mäki‐Torkko, E., Jensen, M., Demeester, K., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm292 · Cited by 137
“Moreover, another transcription factor has been implicated recently in late-onset disease; TCF7L2 (transcription factor 7-like 2) was established as susceptibility gene for type 2 diabetes (41,42).”
BackgroundMaselli, D., Atieh, J., Clark, M. M., Eckert, D., Taylor, A., Carlson, P., Burton, D. D., Busciglio, I., Harmsen, W. S., Vella, A., et al. (2022) · Obesity · doi:10.1002/oby.23481 · Cited by 136
Gustafson, B., & Smith, U. (2012) · Diabetes · doi:10.2337/db11-1419 · Cited by 138
“The reason for the increased WNT activation is unclear, but genetic factors are likely to play an important role and of particular interest are WNT-related genes such as TCF7L2 and Kremen1, where DNA polymorphisms associate with type 2 diabetes and body fat distribution (34,35).”
BackgroundWnt signaling in cardiovascular physiology
Marinou, K., Christodoulides, C., Antoniades, C. A., & Koutsilieris, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.001 · Cited by 147
Genetic approaches to human renal agenesis/hypoplasia and dysplasia
Sanna‐Cherchi, S., Caridi, G., Weng, P. L., Scolari, F., Perfumo, F., Gharavi, A. G., & Ghiggeri, G. M. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0479-1 · Cited by 150
“Similarly, polymorphisms in the transcription factor TCF7L2 have been found to confer risk to type 2 diabetes in different populations [49, 50].”
BackgroundAlterations in TCF7L2 expression define its role as a key regulator of glucose metabolism
Savic, D., Ye, H., Aneas, I., Park, S.-Y., Bell, G. I., & Nobrega, M. A. (2011) · Genome Research · doi:10.1101/gr.123745.111 · Cited by 137
“46 (Cauchi et al. 2007; Grant et al. 2006; Lyssenko 2008).”
BackgroundInfluentialWorldwide population differentiation at disease-associated SNPs
Myles, S., Davison, D., Barrett, J., Stoneking, M., & Timpson, N. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-22 · Cited by 133
“rs10946398 T2D [27, 31] 6 20769013 CDK AL1 0.”
InfluentialPathomechanisms of Type 2 Diabetes Genes
Staiger, H., Machicao, F., Fritsche, A., & Häring, H.-U. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0017 · Cited by 133
Florez, J. C., Jablonski, K. A., Sun, M. W., Bayley, N., Kahn, S. E., Shamoon, H., Hamman, R. F., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2275 · Cited by 132
“56 and high statistical significance (38).”
Watanabe, R. M., Allayee, H., Xiang, A. H., Trigo, E., Hartiala, J., Lawrence, J. M., & Buchanan, T. A. (2007) · Diabetes · doi:10.2337/db06-1682 · Cited by 132
“01) AIR (pmol/l 10 min) 1,990 (2,648) 2,572 (2,788) 3,044 (3,610) 2,974 (2,348) DI 780 (780) 1,141 (1,145) 1,339 (1,106) 1,714 (972)”
BackgroundInfluentialRecent advances in the molecular genetics of type 2 diabetes mellitus
Brunetti, A., Chiefari, E., & Foti, D. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.128 · Cited by 129
Ganesh, S. K., Arnett, D. K., Assimes, T. L., Basson, C. T., Chakravarti, A., Ellinor, P. T., Engler, M. B., Goldmuntz, E., Herrington, D. M., Hershberger, R. E., et al. (2013) · Circulation · doi:10.1161/01.cir.0000437913.98912.1d · Cited by 127
Bodhini, D., Radha, V., Dhar, M., Narayani, N., & Mohan, V. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.012 · Cited by 148
“Recently, Grant et al [5] reported that the transcription factor 7–like 2 (TCF7L2) gene was”
BackgroundResultInfluentialLearning From Molecular Genetics
McCarthy, M. I., & Hattersley, A. T. (2008) · Diabetes · doi:10.2337/db08-0343 · Cited by 147
“Variants within TCF7L2 have 2892 DIABETES, VOL. 57, NOVEMBER 2008 the largest effects seen so far, with a per-allele OR of 1.4 (57): the 15% of Europeans carrying two copies of the risk allele are at approximately twice the lifetime risk of type 2 diabetes as the 40% who have none.”
BackgroundInfluentialSailani, M. R., Halling, J. F., Møller, H. D., Lee, H., Plomgaard, P., Pilegaard, H., Snyder, M. P., & Regenberg, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37895-8 · Cited by 129
Current Understanding on Role of the Wnt Signaling Pathway Effector TCF7L2 in Glucose Homeostasis
Jin, T. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1146 · Cited by 147
Identification of Type 2 Diabetes Genes in Mexican Americans Through Genome-Wide Association Studies
Hayes, M. G., Pluzhnikov, A., Miyake, K., Sun, Y., Ng, M. C. Y., Roe, C. A., Below, J. E., Nicolae, R. I., Konkashbaev, A., Bell, G. I., et al. (2007) · Diabetes · doi:10.2337/db07-0482 · Cited by 129
“CDKN2A, HHEX, HNF4A, IGF2BP2, KCNJ11, PPARG, SLC30A8, and TCF7L2 (20-25), but none account for a large proportion of the risk of developing T2D in the particular population under study nor are any seen universally across all populations.”
BackgroundInfluentialWelt, C. K., Arason, G., Gudmundsson, J. A., Adams, J., Palsdóttir, H., Gudlaugsdóttir, G., Ingadóttir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1191 · Cited by 127
Fu, H., Cai, J., Clevers, H., Fast, E., Gray, S., Greenberg, R., Jain, M. K., Ma, Q., Qiu, M., Rowitch, D. H., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0160-09.2009 · Cited by 127
Timpson, N. J., Lindgren, C. M., Weedon, M. N., Randall, J., Ouwehand, W. H., Strachan, D. P., Rayner, N. W., Walker, M., Hitman, G. A., Doney, A. S. F., et al. (2009) · Diabetes · doi:10.2337/db08-0906 · Cited by 127
“Associations between TCF7L2 genotype and BMI in case subjects have been observed in several previous studies (16,17): our case data provide further evidence of these effects, while also confirming that no BMI association is evident in control subjects (Supplementary Table S4).”
ResultThe GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes?
Portha, B., Lacraz, G., Kergoat, M., Homo-Delarche, F., Giroix, M.-H., Bailbé, D., Gangnerau, M.-N., Dolz, M., Tourrel‐Cuzin, C., & Movassat, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.013 · Cited by 141
At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia
Hansen, T. F., Ingason, A., Djurovic, S., Melle, I. S., Fenger, M., Gústafsson, Ó., Jakobsen, K. D., Rasmussen, H. B., Tosato, S., Rietschel, M., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.031 · Cited by 145
TCF7L2: the biggest story in diabetes genetics since HLA?
Zeggini, E., & McCarthy, M. I. (2006) · Diabetologia · doi:10.1007/s00125-006-0507-x · Cited by 138
“The limited data so far available from more comprehensive genotyping efforts across the gene [12, 17, 20] suggest that the SNPs reported in the Icelandic study (and typed in most subsequent studies) have the strongest association with type 2 diabetes.”
BackgroundResultInfluentialWen, J., Rönn, T., Olsson, A., Yang, Z., Lu, B., Du, Y., Groop, L., Ling, C., & Hu, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009153 · Cited by 127
“The TCF7L2 polymorphism rs7903146 is the strongest single genetic variant associated with type 2 diabetes [4,5,7,8,10] and has been convincingly replicated in multiple populations [27–30].”
BackgroundGenetics of polycystic ovary syndrome
Mykhalchenko, K., Lizneva, D., Trofimova, T., Walker, W., Suturina, L., Diamond, M. P., & Azziz, R. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1340833 · Cited by 98
“The transcription factor 7-like 2 (TCF7L2) gene is involved in embryogenesis, cell proliferation, and normal development of the pancreas and pancreatic islets, and SNPs rs7903146 and rs12255372 of TCF7L2 are known to be associated with the development of T2DM [35,36].”
BackgroundInfluentialThe Genetic Basis of Metabolic Disease
Barroso, I., & McCarthy, M. I. (2019) · Cell · doi:10.1016/j.cell.2019.02.024 · Cited by 124
Blackman, S. M., Hsu, S., Ritter, S. E., Naughton, K. M., Wright, F. A., Drumm, M. L., Knowles, M. R., & Cutting, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1436-2 · Cited by 106
“Greater diabetes risk was associated with the same TCF7L2 allele in CF as in the general population [16], indicating that this genetic risk factor is shared by these two forms of diabetes.”
Type 2 diabetes: pathogenesis and treatment
Stümvoll, M., Goldstein, B. J., & van Haeften, T. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60932-0 · Cited by 159
Platelets and diabetes mellitus
Santilli, F., Simeone, P., Liani, R., & Davì, G. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.002 · Cited by 149
Gaulton, K. J., Willer, C. J., Li, Y., Scott, L. J., Conneely, K. N., Jackson, A. U., Duren, W. L., Chines, P. S., Narisu, N., Bonnycastle, L. L., et al. (2008) · Diabetes · doi:10.2337/db07-1731 · Cited by 122
“Among these are the Pro12Ala (rs1801282) variant in peroxisome proliferator–activated receptor (PPARG) (6), the Glu23Lys (rs5210) variant in the potassium channel gene KCNJ11 (7), and several variants in the Wntreceptor signaling pathway member TCF7L2 (8).”
BackgroundInfluentialType 2 Diabetes TCF7L2 Risk Genotypes Alter Birth Weight: A Study of 24,053 Individuals
Freathy, R. M., Weedon, M. N., Bennett, A. J., Hyppönen, E., Relton, C. L., Knight, B. A., Shields, B. M., Parnell, K. S., Groves, C. J., Ring, S. M., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518517 · Cited by 137
“The gene encoding transcription factor 7–like 2 (TCF7L2 [MIM 602228]) is the most important type 2 diabetes susceptibility gene found to date.(35) Since its discovery, the association has been replicated in subjects of U.”
BackgroundMurdolo, G., Piroddi, M., Luchetti, F., Tortoioli, C., Canonico, B., Zerbinati, C., Galli, F., & Iuliano, L. (2012) · Biochimie · doi:10.1016/j.biochi.2012.12.014 · Cited by 141
“While genetic factors are likely to play a role [69,70], a dysregulated secretion of “endogenous” Wnt antagonists has recently been postulated [27,61,71,72].”
BackgroundWang, M., Helzlsouer, K. J., Smith, M. W., Hoffman–Bolton, J., Clipp, S. L., Grinberg, V. B., Marzo, A. M. D., Isaacs, W. B., Drake, C. G., Shugart, Y. Y., et al. (2009) · The Prostate · doi:10.1002/pros.20933 · Cited by 131
Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
Kanbay, M., Siriopol, D. C., Sağlam, M., Kurt, Y. G., Gök, M., Çetinkaya, H., Karaman, M., Ünal, H. U., Oğuz, Y., Sarı, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2042 · Cited by 123
“Numerous data now implicate the Wnt pathway in metabolic disease (27, 28).”
BackgroundProfiling of circulating microRNAs in children with recent onset of type 1 diabetes
Erener, S., Marwaha, A., Tan, R., Panagiotopoulos, C., & Kieffer, T. J. (2017) · JCI Insight · doi:10.1172/jci.insight.89656 · Cited by 135
“1 0insight.jci.org https://doi.org/10.1172/jci.insight.89656 Hyperglycemia is common to both T1D and T2D, and HbA1c levels provide an indication of blood glucose levels in the recent preceding months.”
BackgroundInfluentialErythropoietin and Oxidative Stress
Maiese, K., Chong, Z., Hou, J., & Shang, Y. (2008) · Current Neurovascular Research · doi:10.2174/156720208784310231 · Cited by 120
Habenular TCF7L2 links nicotine addiction to diabetes
Duncan, A., Heyer, M. P., Ishikawa, M., Caligiuri, S. P. B., Liu, X.-A., Chen, Z., Micioni Di Bonaventura, M. V., Elayouby, K. S., Ables, J. L., Howe, W. M., et al. (2019) · Nature · doi:10.1038/s41586-019-1653-x · Cited by 119
The Arrestin Domain-Containing 3 Protein Regulates Body Mass and Energy Expenditure
Patwari, P., Emilsson, V., Schadt, E. E., Chutkow, W. A., Lee, S., Marsili, A., Zhang, Y., Dobrin, R., Cohen, D. E., Larsen, P. R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.011 · Cited by 120
“(Grant et al., 2006).”
Self-citationGenome-wide association studies and type 2 diabetes
Wheeler, E., & Barroso, I. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr008 · Cited by 119
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
Fang, X., Miao, R., Wei, J., Wu, H., & Tian, J. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.030 · Cited by 125
“In 2006, Grant et al. reported that variation in TCF7L2 expression was closely associated with T2DM risk in a case-control study on Caucasians in Iceland, Denmark, and the United States [27].”
BackgroundDevelopmental Origins of Adult Disease
Simmons, R. A. (2009) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2009.03.004 · Cited by 118
“The recently described type 2 diabetes susceptibility gene Transcription Factor7like 2 (TCF7L2) confers a risk-allele frequency of approximately 30%.(38) Studies of nondiabetic subjects show that TCF7L2 diabetes-risk genotypes alter insulin secretion.”
New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function
Perry, J. R., & Frayling, T. M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32830349a1 · Cited by 117
Role of WNT pathway in the determination of human mesenchymal stem cells into preadipocytes
Laudes, M. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-10-0169 · Cited by 117
Yu, M. S., Qin, K. H., Fan, J., Zhao, G., Zhao, P., Zeng, W., Chen, C., Wang, A., Wang, Y., Zhong, J., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.04.042 · Cited by 147
van Vliet‐Ostaptchouk, J. V., Shiri‐Sverdlov, R., Zhernakova, A., Strengman, E., van Haeften, T. W., Hofker, M. H., & Wijmenga, C. (2006) · Diabetologia · doi:10.1007/s00125-006-0477-z · Cited by 125
“5 Mb interval on 10q identified one microsatellite marker, DG10S478 in intron 3 of the TCF7L2 gene, as being strongly associated with type 2 diabetes (p 1⁄4 2:1 10 9) [3].”
BackgroundAngus-Hill, M. L., Elbert, K. M., Hidalgo, J., & Capecchi, M. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102300108 · Cited by 121
“In addition to CRC and CCRCC, Tcf7L2 polymorphisms have been associated with diabetes, breast cancer, and gastric carcinoma (9, 10, 34).”
BackgroundType 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives
Virally, M., Blickle, J., Girard, J. R., Halimi, S., Simon, D., & Guillausseau, P.-J. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.07.001 · Cited by 162
The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008
Florez, J. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1345 · Cited by 117
Khoury, M. J., Little, J., Gwinn, M., & Ioannidis, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dyl253 · Cited by 119
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.